Lakeshore Biopharma (LSB) to Release Earnings on Monday

Lakeshore Biopharma (NASDAQ:LSB) is projected to post its quarterly earnings results before the market opens on Monday, January 27th. Analysts expect Lakeshore Biopharma to post earnings of ($0.80) per share for the quarter.

Lakeshore Biopharma Stock Up 12.9 %

LSB opened at $2.63 on Friday. The business has a 50 day moving average price of $2.86 and a two-hundred day moving average price of $3.92. Lakeshore Biopharma has a 1-year low of $1.88 and a 1-year high of $11.20. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.90 and a current ratio of 1.17.

Lakeshore Biopharma Company Profile

LakeShore Biopharma Co, Ltd. engages in the provision of discovering, developing, manufacturing, and commercializing vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on developing PIKA technology platform. It operates through the People’s Republic of China and Other Countries or Regions.